Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China

The objective of this study was to investigate the efficacy and safety of 10-day bismuth quadruple therapy with amoxicillin, tetracycline, or clarithromycin and different doses of rabeprazole for first-line treatment of Helicobacter pylori infection. This multicenter, randomized, parallel-controlled...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yong, Zhu, Zhenhua, Wang, Jiangbin, Zhang, Lingxia, Zhang, Zhenyu, Lu, Hong, Zeng, Zhirong, Chen, Shiyao, Liu, Dongsheng, Lv, Nonghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125573/
https://www.ncbi.nlm.nih.gov/pubmed/29914954
http://dx.doi.org/10.1128/AAC.00432-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125573/
https://www.ncbi.nlm.nih.gov/pubmed/29914954
http://dx.doi.org/10.1128/AAC.00432-18

Ejemplares similares